FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $43,000 | +53.6% | 5,866 | +84.3% | 0.00% | – |
Q2 2023 | $28,000 | +600.0% | 3,182 | +650.5% | 0.00% | – |
Q1 2023 | $4,000 | +33.3% | 424 | +45.7% | 0.00% | – |
Q4 2022 | $3,000 | – | 291 | +1978.6% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 14 | -94.9% | 0.00% | – |
Q2 2022 | $2,000 | +100.0% | 273 | +145.9% | 0.00% | – |
Q1 2022 | $1,000 | – | 111 | +552.9% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 17 | -81.9% | 0.00% | – |
Q3 2021 | $1,000 | -66.7% | 94 | -77.2% | 0.00% | – |
Q2 2021 | $3,000 | -76.9% | 413 | -80.4% | 0.00% | – |
Q1 2021 | $13,000 | +44.4% | 2,111 | +75.2% | 0.00% | – |
Q4 2020 | $9,000 | +800.0% | 1,205 | +625.9% | 0.00% | – |
Q3 2020 | $1,000 | -75.0% | 166 | -66.2% | 0.00% | – |
Q2 2020 | $4,000 | – | 491 | +1344.1% | 0.00% | – |
Q1 2020 | $0 | – | 34 | -55.8% | 0.00% | – |
Q4 2019 | $0 | -100.0% | 77 | -90.4% | 0.00% | – |
Q3 2019 | $4,000 | +300.0% | 805 | +170.1% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 298 | +46.8% | 0.00% | – |
Q1 2019 | $1,000 | -66.7% | 203 | -59.5% | 0.00% | – |
Q4 2018 | $3,000 | -62.5% | 501 | -46.6% | 0.00% | – |
Q3 2018 | $8,000 | +700.0% | 938 | +1259.4% | 0.00% | – |
Q2 2018 | $1,000 | – | 69 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic GP LLC | 2,407,357 | $18,079,251 | 17.55% |
Solas Capital Management, LLC | 1,725,567 | $12,959,008 | 9.07% |
DG Capital Management, LLC | 1,143,099 | $8,584,673 | 4.70% |
HARBERT FUND ADVISORS, INC. | 466,869 | $3,506,186 | 2.56% |
AIGH Capital Management LLC | 373,526 | $2,805,180 | 1.33% |
Southpoint Capital Advisors LP | 4,077,214 | $30,619,877 | 0.68% |
APIS CAPITAL ADVISORS, LLC | 70,000 | $525,700 | 0.68% |
Worth Venture Partners, LLC | 92,636 | $695,696 | 0.41% |
Lion Point Capital, LP | 110,000 | $826,100 | 0.37% |
683 Capital Management, LLC | 300,000 | $2,253,000 | 0.18% |